Matches in Wikidata for { <http://www.wikidata.org/entity/Q99419216> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q99419216 description "article scientifique publié en 2020" @default.
- Q99419216 description "artículu científicu espublizáu n'agostu de 2020" @default.
- Q99419216 description "im August 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q99419216 description "scientific article published on 25 August 2020" @default.
- Q99419216 description "wetenschappelijk artikel" @default.
- Q99419216 description "наукова стаття, опублікована 25 серпня 2020" @default.
- Q99419216 description "գիտական հոդված հրատարակված 2020 թվականի օգոստոսի 25-ին" @default.
- Q99419216 name "Can Wharton jelly derived or adipose tissue derived mesenchymal stem cell can be a treatment option for duchenne muscular dystrophy? Answers as transcriptomic aspect" @default.
- Q99419216 name "Can Wharton jelly derived or adipose tissue derived mesenchymal stem cell can be a treatment option for duchenne muscular dystrophy? Answers as transcriptomic aspect" @default.
- Q99419216 type Item @default.
- Q99419216 label "Can Wharton jelly derived or adipose tissue derived mesenchymal stem cell can be a treatment option for duchenne muscular dystrophy? Answers as transcriptomic aspect" @default.
- Q99419216 label "Can Wharton jelly derived or adipose tissue derived mesenchymal stem cell can be a treatment option for duchenne muscular dystrophy? Answers as transcriptomic aspect" @default.
- Q99419216 prefLabel "Can Wharton jelly derived or adipose tissue derived mesenchymal stem cell can be a treatment option for duchenne muscular dystrophy? Answers as transcriptomic aspect" @default.
- Q99419216 prefLabel "Can Wharton jelly derived or adipose tissue derived mesenchymal stem cell can be a treatment option for duchenne muscular dystrophy? Answers as transcriptomic aspect" @default.
- Q99419216 P1433 Q99419216-3B917506-02EC-469F-9DAB-4D8F1C482AF7 @default.
- Q99419216 P1476 Q99419216-C49108B5-ABB7-4AE2-A478-20279474008A @default.
- Q99419216 P2093 Q99419216-2974EDA3-6B6B-4B64-A276-118F26D0361B @default.
- Q99419216 P2093 Q99419216-CAE4CA67-98DD-4EC4-BE36-DB81427A1626 @default.
- Q99419216 P304 Q99419216-E6A5C95B-4283-40FD-9517-3666E11A41A2 @default.
- Q99419216 P31 Q99419216-58F85F33-AA40-42AD-AAA7-6EF493CB8EB2 @default.
- Q99419216 P433 Q99419216-21FAB56A-1154-489B-A12A-92CD6F064BB1 @default.
- Q99419216 P478 Q99419216-00529D93-74D5-4057-855D-A37F92D73F2A @default.
- Q99419216 P577 Q99419216-597492A3-1589-4F56-B19F-1468D82996C5 @default.
- Q99419216 P698 Q99419216-2238F82B-466D-4FF2-A834-9DE995A3FB3D @default.
- Q99419216 P921 Q99419216-74DC0F8D-4638-4639-B15D-31169491EFD0 @default.
- Q99419216 P698 32929392 @default.
- Q99419216 P1433 Q27724047 @default.
- Q99419216 P1476 "Can Wharton jelly derived or adipose tissue derived mesenchymal stem cell can be a treatment option for duchenne muscular dystrophy? Answers as transcriptomic aspect" @default.
- Q99419216 P2093 "Eda Sun" @default.
- Q99419216 P2093 "Erdal Karaoz" @default.
- Q99419216 P304 "57-67" @default.
- Q99419216 P31 Q13442814 @default.
- Q99419216 P433 "4" @default.
- Q99419216 P478 "9" @default.
- Q99419216 P577 "2020-08-25T00:00:00Z" @default.
- Q99419216 P698 "32929392" @default.
- Q99419216 P921 Q1922379 @default.